Navigation Links
BMP Sunstone Reports First Quarter 2008 Financial Results
Date:5/19/2008

o-chemical medicines, medical applications, branded generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipments. BMP Sunstone's proprietary portfolio primarily focuses on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about our acquisitions, joint ventures and management team being able to generate successful results for 2008 and any information regarding guidance for our results for future periods. These statements are subject to uncertainties and risks including, but not limited to, our ability to generate additional revenue, control our expenses and take advantage of synergies between our various subsidiaries and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

BMP SUNSTONE CORPORATION

CONSOLIDATED BALANCE SHEET

($ in thousands)

March 31, December 31,

2008 2007

Assets'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
2. BMP Sunstone Announces Participation in May Investor Conferences
3. BMP Sunstone to Report First Quarter 2008 Financial Results
4. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
5. Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008
6. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
7. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
8. China Yingxia International, Inc. Reports First Quarter 2008 Results
9. Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008
10. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
11. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., Calif., Jan. 8 Digirad...r of medical diagnostic imaging systems and,perso... offices, hospitals and,imaging centers, today an...ll,be presenting at J.P. Morgan,s 27th Annual Hea...he Westin St. Francis Hotel, San Francisco. , ...
(Date:1/8/2009)... In response to the growing consumer d...cians performing these procedures has also skyrock...he industry. Selecting a board-certified surgeon w...c Surgery (ASBS) helps ensure safe, permanent weig...) January 8, 2009 -- Due to the increasing popular...
(Date:1/8/2009)... The healthcare industry is hale and h...ienced massive layoffs lately. NursingCrossing, a ...12,255 nursing jobs in a single week, bringing the...e growing job count in the nursing profession, Nur...and every job opening. , ...
(Date:1/8/2009)... Hall and Praeger to discuss potential...liday party plans, the dangers of federal regulati... Size Me, crowd and more. , ...- Sandy Praeger, Insurance Commissioner for the st...10 at 12 pm CST, on Cary Hall,s Health Insurance ...
Breaking Medicine News(10 mins):Health News:Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco 2Health News:Choosing a Highly-Trained Bariatric Surgeon Crucial as Surgical Weight Loss Procedures Rise and Less-Qualified Doctors Flood the Market 2Health News:Choosing a Highly-Trained Bariatric Surgeon Crucial as Surgical Weight Loss Procedures Rise and Less-Qualified Doctors Flood the Market 3Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 2Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 3Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 2Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 3
...he government's lackluster response to the dengue ...d the MCD have been// ordered to file an affidavit... Dengue Action plan was provided Rs 11372 cr to ta...e dengue outbreak, but still nothing concrete seem...
...e wholly owned subsidiary of Indian pharma major R...nto a tie-up with Janssen-Ortho Inc. (JOI) for mar...a. The second product to be commercialised by RPCI... label RAN under the licensing and supply agreemen...
...nd being tested by researchers ...tute in La Jolla, California, for its ability to e... in the brain, in order to prevent the formation o... Alzheimer’s patients. Researchers said, "Our res...
...ng full steam to counter skin diseases that are p... spread of tinea(fungal infections),scabies and ot...infants living in the ,far flung interior aborigin...and effective treatment for the same. Poverty an...
Other Medicine News:
(Date:1/6/2009)..., Md., Jan. 6 Sequella,...focused on diseases of epidemic potential, announc...he treatment of tuberculosis (TB), was the first d...nical program contract to Dynport Vaccine Company ...rded by the National Institute of Allergy and Infe...
(Date:1/5/2009)...SDA, Md., Jan. 5 Microme...mpany developing novel, proprietary,antibodies fo...mune diseases,provides an outlook on key events ... intends to provide an update on its research and ..., -- April 12 to 16, 2009: Update on several p...
(Date:12/27/2008)...,S, Bermuda, Dec. 23 War...oday that one of its subsidiaries and Mayne Pharma...f Hospira, Inc., have filed lawsuits against each ... Mylan Pharmaceuticals Inc. ("Mylan") and Impax La...for the District of New Jersey for infringement of...
(Date:12/17/2008)...st, Most Complex of Its Kind; 80 Percent of Trauma... Dec. 17 A multi-disciplinary team...tly performed the first near-total face transplan...rocedure performed within the past two weeks, surg... suffered severe facial trauma -- essentially repl...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3FSU Historians Arctic research has him sitting on top of the world 5651 1FSU Historians Arctic research has him sitting on top of the world 5651 2FSU Historians Arctic research has him sitting on top of the world 5651 3Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 1Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 2Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 3Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 4Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 1Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 2Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 3Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 4Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 5Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 6Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 7Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 8Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 9Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 10Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 11Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 12XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results 28172 1XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results 28172 2
... Pending Final Analysis of the Results, ISTA Plans...-, IRVINE, Calif., May 31, 2007 /PRNewswire-FirstC...ed positive results from the,preliminary analysis ...t sodium, which is being developed as a treatment ...m group achieved a strong,trend in the objective s...
...EVERLY HILLS, Calif.--(BUSINESS WIRE)--May 31, 200...rom an online survey of Suboxone,users, indicating...uboxone, also known as Subutex or Buprenorphine, b...sistance, indicating a,physical dependency. Suboxo...tes including OxyContin, Vicodin, Lortab or,Fentan...
Other Medicine Technology:ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5Waismann Method Survey Reveals Dependency Risk for People Using,Suboxone 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: